ATH
Click for more information
11.1% 0.5¢ alterity therapeutics limited

Experimental method to study macula degeneration, page-5

  1. gumboot
    383 Posts.
    lightbulb Created with Sketch. 19
    clock Created with Sketch.
    12/10/21
    10:11
    Post #: 56729960
    Here's some news.
    The FDA has awarded a failed Alzheimers drug from Roche breakthrough therapy designation 10 years after it was rejected after failing trials.
    It hit some amyloid targets but was tossed after failing common test standards.
    Perhaps they could review the canine standard for PBT2
    ATH Price at posting: 3.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
HAR Haranga resource upgrade builds confidence in Saraya uranium project
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.001(11.1%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $14.25K 2.930M

Buyers (Bids)

No. Vol. Price($)
66 81346070 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19609447 23
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.